TS vs. ABBV
TS (Tenaris S.A.) and ABBV (AbbVie Inc.) are both stocks. TS operates in Oil & Gas Equipment & Services (Energy), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, TS returned 10.97%/yr vs 19.47%/yr for ABBV. At a 0.20 correlation, their price movements are largely independent.
Performance
TS vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TS achieves a 53.90% return, which is significantly higher than ABBV's 4.43% return. Over the past 10 years, TS has underperformed ABBV with an annualized return of 10.97%, while ABBV has yielded a comparatively higher 19.47% annualized return.
TS
- 1D
- -0.21%
- 1M
- -5.81%
- YTD
- 53.90%
- 6M
- 54.10%
- 1Y
- 68.22%
- 3Y*
- 31.75%
- 5Y*
- 24.78%
- 10Y*
- 10.97%
ABBV
- 1D
- 2.07%
- 1M
- 8.84%
- YTD
- 4.43%
- 6M
- 4.29%
- 1Y
- 31.92%
- 3Y*
- 24.36%
- 5Y*
- 19.80%
- 10Y*
- 19.47%
TS vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TS Tenaris S.A. | 53.90% | 4.98% | 12.88% | 2.63% | 73.26% | 34.03% | -28.87% | 9.68% | -31.51% | -6.68% |
ABBV AbbVie Inc. | 4.43% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between TS and ABBV is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.20 |
The correlation between TS and ABBV shifts across timeframes, from 0.10 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.
Fundamentals
TS:
$14.53B
ABBV:
$416.46B
TS:
$4.26
ABBV:
$2.05
TS:
13.63
ABBV:
114.38
TS:
2.20
ABBV:
6.63
TS:
0.85
ABBV:
15.14
TS:
$12.16B
ABBV:
$62.82B
TS:
$3.89B
ABBV:
$46.15B
TS:
$3.16B
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TS vs. ABBV — Risk / Return Rank
TS
ABBV
TS vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tenaris S.A. (TS) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TS | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.11 | ||
| Sortino ratioReturn per unit of downside risk | +1.11 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.24 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 5.16 | 1.85 | +3.31 |
| Martin ratioReturn relative to average drawdown | 13.50 | 4.11 | +9.38 |
Loading charts...
Drawdowns
TS vs. ABBV - Drawdown Comparison
The maximum TS drawdown since its inception was -83.34%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for TS and ABBV.
Loading charts...
Drawdown Indicators
| TS | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.34% | -45.09% | -38.25% |
Max Drawdown (1Y)Largest decline over 1 year | -13.28% | -17.32% | +4.04% |
Max Drawdown (3Y)Largest decline over 3 years | -29.81% | -20.74% | -9.07% |
Max Drawdown (5Y)Largest decline over 5 years | -33.71% | -21.92% | -11.79% |
Max Drawdown (10Y)Largest decline over 10 years | -76.21% | -45.09% | -31.12% |
Current DrawdownCurrent decline from peak | -9.36% | -1.66% | -7.70% |
Average DrawdownAverage peak-to-trough decline | -36.73% | -10.70% | -26.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.07% | 7.78% | -2.71% |
Volatility
TS vs. ABBV - Volatility Comparison
Tenaris S.A. (TS) and AbbVie Inc. (ABBV) have volatilities of 9.32% and 9.26%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TS | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.32% | 9.26% | +0.06% |
Volatility (6M)Calculated over the trailing 6-month period | 21.01% | 19.11% | +1.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.91% | 25.23% | +3.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.65% | 23.12% | +10.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.75% | 25.83% | +10.92% |
Dividends
TS vs. ABBV - Dividend Comparison
TS's dividend yield for the trailing twelve months is around 3.07%, more than ABBV's 2.87% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.87% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
TS Tenaris S.A. | 3.07% | 2.96% | 3.55% | 3.11% | 2.56% | 2.59% | 0.88% | 3.62% | 3.85% | 4.39% | 2.41% | 3.78% |
Financials
TS vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Tenaris S.A. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TS vs. ABBV - Profitability Comparison
TS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tenaris S.A. reported a gross profit of 1.05B and revenue of 3.11B. Therefore, the gross margin over that period was 33.9%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
TS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tenaris S.A. reported an operating income of 585.67M and revenue of 3.11B, resulting in an operating margin of 18.8%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
TS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tenaris S.A. reported a net income of 542.67M and revenue of 3.11B, resulting in a net margin of 17.4%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
TS and ABBV have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TS has higher volatility (9.32%) compared to ABBV (9.26%). In terms of maximum drawdown, TS dropped -83.34% vs ABBV's -45.09%.
TS currently has the higher Sharpe Ratio (2.38 vs 1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TS and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer